LeafNLP Demos
Back to explore

Report #2878385

Received Dec 17, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
TX
Recovered
Unknown
Vaccinated
Dec 9, 2025
Onset
Dec 9, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (ENGERIX-B)GLAXOSMITHKLINE BIOLOGICALSUNK42D7A—

Symptoms (1)

Underdose

Symptom narrative

Engerix B pediatric dose given to adult patient; Engerix B pediatric dose given to adult patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult use of a child product in a 66-year-old female patient who received HBV (Engerix B pediatric) (batch number 42D7A, expiry date 25-JUL-2026) for prophylaxis. On 09-DEC-2025, the patient received Engerix B pediatric. On 09-DEC-2025, an unknown time after receiving Engerix B pediatric, the patient experienced adult use of a child product (Verbatim: Engerix B pediatric dose given to adult patient) and underdose (Verbatim: Engerix B pediatric dose given to adult patient). The outcome of the adult use of a child product and underdose were not applicable. Additional Information: GSK Receipt Date: 11-DEC-2025 The Vaccine Administration Facility was the same as Primary Reporter A clinic supervisor reported that a pediatric dose of Engerix B was given to an adult patient. Supervisor mentioned patient that received the vaccine was an employee at their facility.